from Google Alert at http://bit.ly/2r3ymJN on October 31, 2019 at 10:09PM After years of lobbying by experts and advocacy groups, people with eating disorders will now be able to access more Medicare subsidised treatment, …
from Google Alert at http://bit.ly/2WBiIRt on October 31, 2019 at 09:26PM A recent Tufts Center for the Study of Drug Development study published in the Journal of Health Economics concluded the cost of developing a new …
from Google Alert at http://bit.ly/2NtOdc1 on October 31, 2019 at 09:26PM It’s pretty much stagnant, so 2.5% seems unlikely,” said Dr Sakthivel Selvaraj, director, health economics and policy, Public Health Foundation of India.
from Google Alert at http://bit.ly/2PB3YQY on October 31, 2019 at 09:26PM Eversana has agreed to acquire Burlington, Ontario-based Cornerstone Research Group Inc, a provider of health economics and outcomes research …
from Google Alert at http://bit.ly/327xfoZ on October 31, 2019 at 09:26PM The CLSA and Biocom commissioned study was conducted by Vital Transformation, an international health economics firm, to examine the impact of …
from Google Alert at http://bit.ly/2WtCtKC on October 31, 2019 at 09:26PM Both interns were placed at Allergan’s Global Health Economics and Outcomes Research department in Irvine, Calif., with a rotation at …
from Healthcare Economist at http://bit.ly/335QxMV on October 31, 2019 at 07:37PM Deficit nears $1 trillion. Pelosi’s reference pricing bill. Gates Foundation to develop gene therapies. Was the ACA anti-marriage? Physician payment and lab test ordering. Patent buy-outs.
from Google Alert at http://bit.ly/2WvXS5T on October 31, 2019 at 06:59PM His preceptor was Genentech Associate Health Economist Sheila Shapouri, PharmD, MS. Ko’s research on A Targeted Literature Review on the …
from Google Alert at http://bit.ly/2JGm5l0 on October 31, 2019 at 06:05PM 2019 Health Economics Research Centre | Nuffield Department of Population Health | University of Oxford | Richard Doll Building | Old Road Campus …
from Health Economics and Decision Science Blog @ ScHARR at http://bit.ly/3385Q7S on October 31, 2019 at 05:29PM Sarah Davis Sarah Davis is a co-investigator on The BLAST OFF (Bisphosphonate aLternAtive regimenS for the prevenTion of Osteoporotic Fragility Fractures) Study. The aim of the research is to determine the most effective, cost-effective, acceptable and safe alternative […]
from AcademyHealth Blog at http://bit.ly/2JF99vz on October 31, 2019 at 05:10PM The Power of Person-Generated Health Data: Five Ways to Improve the Care Experience The use of technology in health care has improved many aspects of the way the health system works. Consumers can order prescription refills and schedule appointments online. Electronic health records (EHRs) […]
from PharmacoEconomics – Open at http://bit.ly/31YVjdH on October 31, 2019 at 03:34PM Abstract Objective Our objective was to assess the cost effectiveness of apixaban versus edoxaban in the prevention of stroke and systemic embolism (SE) in patients with atrial fibrillation (AF) in Spain. Methods We customized a Markov model with ten health states to estimate […]
from Google Alert at http://bit.ly/323mxji on October 31, 2019 at 02:52PM Un véritable fléau qui a pourtant un bon côté, d’après une étude parue dans le numéro de décembre du Journal of Health Economics. Les chercheurs …
from Market Design at http://bit.ly/36kC69U on October 31, 2019 at 12:37PM Here’s a clear-eyed account of Global Kidney Exchange, from three moral philosophers, forthcoming in The Lancet. You can read the whole thing at the link: The ethics of the Global Kidney Exchange programmeFrancesca Minerva, Julian Savulescu, Peter SingerThe Lancet (online first, Published:October 29, 2019 […]
from tHEORetically Speaking: The HealthEconomics.Com Blog at http://bit.ly/34fihim on October 31, 2019 at 12:14PM The House on Monday, Oct. 28, unanimously passed the Public Disclosure of Drug Discounts Act in a bid to boost transparency in how drugmakers price their drugs, One America News Network reports. The bill now goes to the Senate for full […]
from tHEORetically Speaking: The HealthEconomics.Com Blog at http://bit.ly/34gznfD on October 31, 2019 at 11:44AM Presenters during the 9th Annual Research Symposium, hosted in conjunction with AMCP’s 2019 Nexus meeting, stressed the importance of advancing real-world evidence (RWE) amid data innovations and collaborations, AJMC reports. “We can’t expect this to directly replicate clinical research, but it’s […]
from Google Alert at http://bit.ly/2WqKdgC on October 31, 2019 at 11:39AM In current AJHE: Yao Lu and David J. G. Slusky study the impact of women’s health clinic closures on fertility rates by combining quarterly snapshots of …
from Econsalut at http://bit.ly/2WtZNYJ on October 31, 2019 at 08:37AM Will population ageing spell the end of the welfare state? A review of evidence and policy optionsSustainable health financing with an ageing population: implications of different revenue raising… [[ This is a content summary only. Visit my website for full links, other content, and more! […]
from Google Alert at http://bit.ly/2prZwcN on October 31, 2019 at 08:26AM Αυτό μας λέει πράγματι μια μελέτη που δημοσιεύτηκε στην επιθεώρηση «Journal of Health Economics», ισχυριζόμενη ότι όταν τα επίπεδα της γύρης …
from The European Journal of Health Economics at http://bit.ly/2q9nKIE on October 31, 2019 at 08:18AM Abstract Objective To predict the real-world (RW) cost-effectiveness of carfilzomib in combination with lenalidomide and dexamethasone (KRd) versus lenalidomide and dexamethasone (Rd) in relapsed multiple myeloma (MM) patients after one to three prior therapies. Methods A partitioned survival model that […]
from Health Economics and Decision Science Blog @ ScHARR at http://bit.ly/2PvHIYK on October 31, 2019 at 07:00AM We are currently advertising for the below post in HEDS:Job Title: Clerical OfficerJob Reference Number: UOS024400Closing date: 12.11.2019 Grade 4 £19,612 – £21,814 per annum. Potential to progress to £23,754 per annum through sustained exceptional contribution. ScHARR – Regent Court Further information related […]
from Google Alert at http://bit.ly/331PD4f on October 31, 2019 at 05:24AM It’s not a quick fix for anything. “If we were to move everyone onto Medicare, that would be a ten-year project,” A. James Lee, health economist at AJL …
from Google Alert at http://bit.ly/323qswy on October 31, 2019 at 05:14AM … health, health services, health disparities, health policy, health economics, pharmacoepidemiology and aging research, according to the release.
from Google Alert at http://bit.ly/34lylzf on October 31, 2019 at 05:14AM The next HERU external seminar will be delivered by Dr Yuanyuan Gu. Yuanyuan is currently undertaking a Marie Sklodowska-Curie Fellowship on …
from Healthcare Economist at http://bit.ly/2Jz19My on October 31, 2019 at 02:50AM As you can guess from the title of this post, Spain leads the world in rates of organ donation. More recent figures back this up. Figures published for 2017 reveal that 2,183 people in Spain became organ donors last year after they died. That’s 46.9 […]
from Google Alert at http://bit.ly/2BV9dDa on October 31, 2019 at 02:04AM ANALYSIS/OPINION: When the federal government (rarely) looks to cut costs, it often focuses on the lowest-profile line items. These are the easiest to …
from Google Alert at http://bit.ly/2BXOyhR on October 31, 2019 at 02:02AM “If we were to move everyone onto Medicare, that would be a ten-year project,” A. James Lee, health economist at AJL Health Economics, told …
from Google Alert at http://bit.ly/36kIwpv on October 31, 2019 at 02:02AM In health economics and outcomes research, value assessments are often performed by using published drug prices to determine the average price of …
from Google Alert at http://bit.ly/332NHbF on October 31, 2019 at 02:02AM "By adding a strong health economics and outcomes capability to our integrated commercial platform, we can now conceptualize, deliver and measure …
from Google Alert at http://bit.ly/2BY8iBT on October 31, 2019 at 02:02AM This human rights treaty has the aim of setting out the rights of children in terms of health, economics, social, political, civil and cultural issues.
from AcademyHealth Blog at http://bit.ly/2N0wh9V on October 30, 2019 at 07:15PM States Leverage Medicaid Waivers to Combat Health Challenges, Pilot Funding Approaches and Work Requirements States continue to innovate with their Medicaid programs through 1115 waiver demonstrations, which allow states to “waive” specific requirements of Medicaid and use federal Medicaid funds to support program changes in […]
from The Health Care Blog at http://bit.ly/2qZlEf5 on October 30, 2019 at 03:12PM By ERIN MCKELLE There are many public health conferences that focus on young people, or that center around youth issues, but very few that actually include the young people’s voices that we are claiming to uplift as public health professionals. There are […]
from RAND Research Topic: Health and Health Care at http://bit.ly/2JwmupN on October 30, 2019 at 03:11PM Understanding effects of cannabis laws requires greater attention to differences in short- versus long-term effects of the laws, nuances of policies and patterns of consumption, and careful consideration of appropriate control groups.
from RAND Research Topic: Health and Health Care at http://bit.ly/2NpzXRz on October 30, 2019 at 03:11PM Disaster citizen science, or the use of scientific principles and methods by "non-professional" scientists or volunteers, may be a promising way to enhance public health emergency preparedness and build community resilience.
from tHEORetically Speaking: The HealthEconomics.Com Blog at http://bit.ly/2outRqC on October 30, 2019 at 03:06PM Bipartisan Policy Center Chief Medical Advisor Anand Parekh in a brief interview talks patient-centered outcomes research in the advancement of value-based health care. To watch the interview on YouTube, click here.
from tHEORetically Speaking: The HealthEconomics.Com Blog at http://bit.ly/331RzJJ on October 30, 2019 at 03:06PM A recent article published in BMJ looked at referrals made to the European Medicines Agency between 2013-2017 to assess non-interventional studies in postmarketing assessments. “Non-interventional studies had an important role particularly for the characterisation and quantification of adverse events, the evaluation […]
from The Health Care Blog at http://bit.ly/2qXvnm5 on October 30, 2019 at 03:05PM Today on Health in 2 Point 00… hold on, where’s Jess? On Episode 99, I do a reverse takeover with Priyanka Kashyap and Sophie Park at Bayer’s office in Berlin. Priyanka tells us about what Bayer G4A is doing these days with […]
from RAND Research Topic: Health and Health Care at http://bit.ly/2WqWr8K on October 30, 2019 at 02:13PM The population effects of armed conflict on non-combatant vulnerable populations are incompletely understood. We aimed to study the effects of conflict on mortality among women of childbearing age (15-49 years) and on orphanhood among children younger than 15 years […]
from RAND Research Topic: Health and Health Care at http://bit.ly/2pgIFd1 on October 30, 2019 at 02:13PM This report describes how the U.S. Army can optimize its medical materiel strategies for efficient medical equipping readiness.
from The Incidental Economist at http://bit.ly/32YwyzD on October 30, 2019 at 02:07PM The following originally appeared on The Upshot (copyright 2019, The New York Times Company) American children are more likely to be hit by cars on Halloween than on any other night of the year. But many of the concerns expressed each October — in […]
Health Econ Bot 
You must be logged in to post a comment.